BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,969.34
      0.35%
      US Tech 100
      20,266.40
      0.33%
      Dow Jones
      44,296.51
      0.97%
      Brent Oil
      74.745
      -0.03%
      Bitcoin
      97,956.00
      0.09%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. GE HealthCare Technologies Inc (GEHC) Quote

      GE HealthCare Technologies Inc

      GE HealthCare Technologies Inc (GEHC)

      NASDAQ
      82.44
      0.44
      (0.54%)
      Closed November 24 4:00PM
      Delayed by 15 minutes
      82.80
      0.36
      (0.44%)
      After Hours: 7:56PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      82.80
      Bid
      77.04
      Ask
      92.00
      Volume
      5,895,950
      80.56 Day's Range 82.58
      66.39 52 Week Range 94.55
      Market Cap
      37.829B
      Previous Close
      82.00
      Open
      81.875
      Last Trade
      36
      @
      82.61
      Last Trade Time
      Financial Volume
      $ 480,971,378
      VWAP
      81.5766
      Average Volume (3m)
      3,279,034
      Shares Outstanding
      456,872,979
      Dividend Yield
      0.14%
      PE Ratio
      27.19
      Earnings Per Share (EPS)
      3.03
      Revenue
      19.55B
      Net Profit
      1.39B

      About GE HealthCare Technologies Inc

      GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong ... GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.gehealthcare.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      GE HealthCare Technologies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GEHC. The last closing price for GE HealthCare Technologies was $82. Over the last year, GE HealthCare Technologies shares have traded in a share price range of $ 66.39 to $ 94.55.

      GE HealthCare Technologies currently has 456,872,979 shares outstanding. The market capitalization of GE HealthCare Technologies is $37.46 billion. GE HealthCare Technologies has a price to earnings ratio (PE ratio) of 27.19.

      Ask ADVFN Intelligence (AI)

      GE HealthCare Technologies (GEHC) Options Flow Summary

      GEHC Options Flow

      Overall Flow

      Bearish

      Net Premium

      -239k

      Calls / Puts

      83.33%

      Buys / Sells

      120.00%

      OTM / ITM

      266.67%

      Sweeps Ratio

      0.00%

      GEHC Latest News

      More News

      GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology

      To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added Lung Suite to their OEC 3D m-CBCT offering. OEC Open interface expanded with...

      November 22 2024
      Business Wire

      Form 8-K - Current report

      November 21 2024
      Edgar (US Regulatory)

      GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth

      Company updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17% GE HealthCare (Nasdaq: GEHC) will host its Investor Day today at...

      November 21 2024
      Business Wire

      Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue

      Published in the Journal of Clinical Anesthesia, results from the two-phase, 250 patient pilot study show clinicians found a majority (82%) of the alarms from the wireless and wearable Portrait...

      November 18 2024
      Business Wire

      GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System

      New MRI technology aims to advance neuroimaging and biomarker research GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T high-performance...

      November 13 2024
      Business Wire

      GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage

      Factors impacting today’s critical shortage of radiologic technologists include clinician burnout, the impact of COVID and COVID-related policies, and demand for radiologic technologists...

      November 12 2024
      Business Wire

      GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™

      Collaboration will leverage GE HealthCare’s legacy and scale of imaging innovation and RadNet’s DeepHealth AI-powered clinical and workflow solutions to further the innovation...

      November 11 2024
      Business Wire

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 08 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.210.25426807119582.5985.2981.52400018483.00599411CS
      4-6.46-7.2372843378989.2689.9181.52374719385.29080997CS
      12-1.65-1.9538188277184.4594.5581.52327903488.01128118CS
      261.231.5079073188781.5794.5574.51287723184.21887326CS
      529.0512.271186440773.7594.5566.39298753383.06642987CS
      15628.6752.965084056954.1394.5553.813300856278.11644173CS
      26028.6752.965084056954.1394.5553.813300856278.11644173CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PDYNPalladyne AI Corporation
      $ 4.59
      (129.50%)
      		83.07M
      QMCOQuantum Corporation
      $ 9.11
      (126.62%)
      		39.48M
      NANano Labs Ltd
      $ 8.26
      (89.02%)
      		2.03M
      XCURExicure Inc
      $ 18.60
      (71.27%)
      		4.59M
      SKKSKK Holdings Limited
      $ 1.75
      (59.09%)
      		107.47M
      AMIXAutonomix Medical Inc
      $ 6.21
      (-54.07%)
      		946.09k
      CETXCemtrex Inc
      $ 0.1146
      (-41.74%)
      		24.39M
      MSWMing Shing Group Holdings Ltd
       5.90
      (-35.52%)
      		417.08k
      RMSGReal Messenger Corporation
      $ 3.09
      (-26.25%)
      		313.51k
      ENSCEnsysce Biosciences Inc
      $ 0.4414
      (-25.49%)
      		4M
      ELABElevai Labs Inc
      $ 0.0201
      (-0.50%)
      		425.38M
      NVDANVIDIA Corporation
      $ 141.95
      (-3.22%)
      		236.51M
      SMCISuper Micro Computer Inc
      $ 33.15
      (11.62%)
      		159.61M
      VRPXVirpax Pharmaceuticals Inc
      $ 0.5501
      (-6.72%)
      		159.39M
      SOUNSoundHound AI Inc
      $ 8.24
      (18.05%)
      		107.91M

      Discussion

      View Full Feed
      3331 3331 3 minutes ago
      BIEL: HUGE NEWS - Flagship product RecoveryRX is now available at every Veterans Administration clinic and hospital nationwide!

      https://kellycovemobility.com/rrx/
      An American hero gives a fantastic testimonial about Bioelectronics flagship product - RecoveryRX!
      https://i
      NYBob NYBob 4 minutes ago
      Monument Mining Ltd

      ODY new Corporate Presentation
      As usual, very well done.

      Market cap of $16 million cad .

      Ripe for the picking..

      https://api.investi.com.au/api/announcements/ody/243a8e81-d00.pdf
      MMY
      jimr1717 jimr1717 4 minutes ago
      Maybe this is why they have 60k in revenue.

      No one is fooled
      IFUS
      sortagreen sortagreen 4 minutes ago
      More from the Middle East's flagship democracy

      Israel sanctions Haaretz due to articles that ‘hurt’ Israeli state

      The Haaretz newspaper called the decision ‘another step in Netanyahu’s journey to dismantle Israeli democracy’.

      https://www.aljazeera.com/new
      3331 3331 5 minutes ago
      BIEL: HUGE NEWS - Flagship product RecoveryRX is now available at every Veterans Administration clinic and hospital nationwide!

      https://kellycovemobility.com/rrx/
      An American hero gives a fantastic testimonial about Bioelectronics flagship product - RecoveryRX!
      https://i
      InDa0828 InDa0828 5 minutes ago
      I just realized a we are pink current and still in the Shit&@r! $INND CEO MM when will we see the light to regain our investment after the horrific reverse split that was promised will never happen during October 2023!!!
      INND
      PEACHMAN PEACHMAN 6 minutes ago
      IFUS is loaded every month with news in the U.S.A..There are 58 releases below

      https://www.otcmarkets.com/stock/IFUS/news

      IFUS Letter to Shareholders 11-11-2024Press Release | 11/11/2024
      IFUS Letter to Shareholders 10-30-2024Press Release | 10/30/2024
      IFUS
      IFUS
      AJH92 AJH92 7 minutes ago
      Share Structure - Updated November 25, 2024

      Transfer Agent Verified

      No change - no dilution

      All future acquisitions will use Preferred Z shares

      Authorized Shares: 7,000,000,000

      Outstanding Shares: 3,501,977

      Res
      INCCD
      shajandr shajandr 7 minutes ago
      Poor thinking yields fruitless "solutions": https://www.msn.com/en-us/money/markets/solar-power-glut-boosts-california-electric-bills-other-states-reap-the-benefits/ar-AA1uEMCB?cvid=effb5ac7927e4542a657ede38de61f43&ei=60
      krisrun krisrun 7 minutes ago
      (1) TSLA up > $ 6 on Robinhood.
      (2) Who is a good salesperson ? A person who can sell ice cream in snow storm.
      TSLA
      Fred Kadiddlehopper Fred Kadiddlehopper 8 minutes ago
      I disagree. Stopping a potential competitor like Alteogen in its tracks would benefit Halozyme immensely, IMHO.
      HALO
      OMOLIVES OMOLIVES 8 minutes ago
      lol....no. It doesn't work like that.

      https://www.merriam-webster.com/dictionary/support

      I certainly do not have a problem with the pick because it is not something that needs to be solved. Therefor, it is not a problem.
      $GROO $GROO 8 minutes ago
      your hubris and hatred for Franky, blinds you of the value of saving human lives, around 50% of many dispensaries have gray or counterfeit produfts.  you will be judged by the all mighty.  
      SANP
      janga janga 9 minutes ago
      I thought you'd like this: https://www.ccn.com/news/business/gold-prices-rise-discovery-china-new-record-ahead/
      NBRI
      delerious1 delerious1 9 minutes ago
      This rally is off the charts, as far as I can see it's pure Fundamentals now ...charts are in the rear view mirror
      XRPUSD
      biotechinvestor1 biotechinvestor1 11 minutes ago
      Decease and desist that you referred to in your message, would not benefit Halozyme. Halo  would much rather have either a license fee or some penalty for infringement. The only real entity that would benefit from a C and desist would be brystol Myers, in which case they would be back in Halozyme wi
      HALO
      AJH92 AJH92 11 minutes ago
      Share Structure - Updated November 23, 2024

      Transfer Agent Verified

      No change - no dilution

      Authorized Shares: 2,400,000,000

      Outstanding Shares: 2,115,876,871

      Restricted: 186,002,437

      Unrestricted: 1,929,874,434
      IJJP
      OncoJock OncoJock 12 minutes ago
      Thank you for posting this.

      -- OJ
      HALO
      Fred Kadiddlehopper Fred Kadiddlehopper 13 minutes ago
      To your point, though, it is possible that BMY might be willing to chip in to the HALO legal fund in order to slow or otherwise hamper SC Keytruda's entry into the marketplace, thus strengthening HALO's hand.
      BMY
      OMOLIVES OMOLIVES 13 minutes ago
      I never said it did. And i was replying to Hawks regarding the quote and link coming from some TV guy...which OZ became. As in the guy is just jealous of Oz's carreer. Which is obviously is..lol.
      jimr1717 jimr1717 14 minutes ago
      India? Why no news in the US? I think I know why.
      IFUS
      AJH92 AJH92 14 minutes ago
      Share Structure - Updated November 18, 2024:

      Transfer Agent Verified

      No change - no dilution

      Authorized Shares: 12,000,000,000

      Outstanding Shares: 3,142,243,272

      Restricted: 383,572,035

      Unrestricted: 2,758,671,2
      ECOX
      Jack Torrance Jack Torrance 15 minutes ago
      2025 is shaping up to be a good year. I am in several tickers that seem set to explode in the next 12 months or so.
      MNMD
      Jim Beem Jim Beem 16 minutes ago
      Gotta be tuff pretending to others this is still a winner when clearly it's a loser.


      SEC DELINQUENT NOTICE ON ASII
      ASII

      Your Recent History

      NASDAQ
      GEHC
      GE HealthCare Technologies
      Delayed Upgrade Clock